Pamela Chiesi

Pamela Chiesi - What is Precision Medicine?

Pamela Chiesi graduated with a Bachelor of Science degree in in Electrical Engineering from the University of Michigan. She also holds a Master of Business Administration from The Wharton School, University of Pennsylvania. She has been working in the biopharma industry for fifteen years and has worked hard to build a successful career as a biopharmaceutical commercialization strategist.

What is Precision Medicine?

The National Institute of Health defines precision medicine as “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” Precision medicine will permit researchers and doctors to predict more accurately which treatment will work for a particular disease, in which groups of people. In fact, this stands in contrast to the “one-size-fits-all” approach that has been in use for so many years. Senior level biopharma consultancy strategist Pamela Chiesi says, “Biopharma treatments combined with companion diagnostics have the potential to identify patients with the highest probability of the greatest treatment response. Conceptually, this benefits the targeted patients, their treating physicians, payors who can limit treatment access (and associated costs) to sub-populations and biopharma who may gain preferred access to treating these patient subpopulations.”

Pamela Chiesi also believes that there are several risks to biopharma pursuing this strategy, namely:

• Will the clinical trial design actually show a better treatment response in the target population that can be compared with current standard of care or the trials results of competitors?
• Will the companion diagnostic also receive regulatory approval, access, reimbursement, and uptake?
• What are the financial trade-offs for biopharma of limiting its target population versus uptake within the population?
• What are the implications for the price it must command for this trade-off and subsequent access and uptake?

Source: https://ghr.nlm.nih.gov/primer/precisionmedicine/definition

Pamela Chiesi - The Objectives of Commercialization Strategies

Pamela Chiesi is a biopharma commercial strategist with fifteen years’ experience in the industry. She graduated with a Bachelor of Science degree in Electrical Engineering from the University of Michigan, College of Engineering, Ann Arbor, Michigan in 1986. She continued her education and received her Master of Business Administration degree from the University of Pennsylvania, The Wharton School, Philadelphia, Pennsylvania. Prior to becoming a biopharma commercial strategist, she worked as an engineer at IBM Corporation developing fiber optic channel microcode for mainframe computers.

Pamela Chiesi started working as a consultant with IT strategy and planning in the finance industry with IBM Consulting Group before moving over to Towers Perrin Strategy Consulting – Pharmaceutical Practice in 1994. According to her, the objective of commercialization strategy is to maximize client revenues from products, portfolios, or therapy areas. A couple of points from her understanding of commercialization strategy is as follows.

• Identify the specific strategies and actions that maximize forecasted revenues taking account of:

1. Inline products
2. Pipeline products
3. Competitor actions
4. Other factors (e.g. legislation, social/political issues, M&A dynamics, etc.)

• In the context of key stakeholders:

1. Payers/Budget Holders (MCOs, National/Regional Govt., Hospitals, etc.)
2. Physicians (Prescribers, Key Opinion Leaders)
3. Patient sub-populations across settings of care

• Recommendations are stress-tested using:

1. Sensitivity analysis
2. Contingency plans
3. Considerations of what one would have to believe for the recommendations to change

Pamela Chiesi is a senior level biopharmaceutical strategy consultant who is committed to helping clients maximize revenue using market access, pricing, reimbursement, clinical development, and negotiation and contracting strategies.

Pamela Chiesi - Challenges of the Evolving Healthcare Payer Environment

Speaking at The Economist’s Thirteenth Annual Pharmaceutical Conference in London, Pamela Chiesi said, “predictably, payers are applying management tools to curtail the growth in budget impact, thereby putting pharma profits at risk.” Governments are finding that the healthcare in the largest single item of public expenditure, particularly in the cost of drugs. With the constant increase in growth rates faster that the GDP, drug prices are threatening the long-term viability of health care systems.

Pamela Chiesi has been in a biopharma commercialization strategist for fifteen years and has extensive knowledge of the industry. According to her, the challenge faced by the drug industry is to defend a premium price without sacrificing access or volume. She went on to show that the problem was that the strategy used by the drug industry was to develop superior products that were able to command a premium price. She stated that the products that were most at risk for potential access restriction were those that were considered not to offer superiority, such as thiazolidinediones (TDZ), beta interferons, atypicals, branded selective serotonin reuptake inhibitors (SSRI), Avastin (bevacizumab), dopamine agonists, Erbitux (cetuximab), Nexavar (sorafenib), and Sutent (sunitinib malate).

Pamela Chiesi noted that in the United States, payers were expecting head-to-head trials against gold standard treatments that demonstrated superiority on key endpoints. She also said, “Statistically significant is no longer adequate, payers want real outcomes data.” Ms. Chiesi also examined the German reference pricing system and argued that it threatens to undermine the future market for various classes of drugs.

Pamela Chiesi - Advice For New Online Stock Traders

After making the decision to transition away from the biopharma space in 2009, Pamela Chiesi began working for GCI Financial, LLC alongside her late fiancé, then the company’s Chief Administrative Officer , and has gained a certain level of expertise in online stock trading and the forex industry as a result. Those who are new to online stock trading are often prone to making mistakes due to inexperience, so try to keep the following in mind to ensure you make wise investments.

Know Your Trading Style
Before you can start getting really involved with online stock trading, you need to understand the style that suits you best and fits around your current lifestyle. You have a choice between a wide range of styles, including day trading, short-term trading and weekly or monthly trading, so it is important that you plan your route to success and stick to one style at a time.

Understand The Risk
Stock trading on any level involves a certain amount of risk, so your aim should be to mitigate this risk as far as possible, while also giving yourself the highest prospects of making strong returns. Risk management may not be the most exciting aspect of online stock trading, but it is crucial to your long-term success as it will allow you to control your investments.

Invest in Education
Pamela Chiesi points out that good education helps, regardless of your industry. Those who feel they can enter online stock trading completely blind often find that their investments fail, so take advantage of any educational opportunities that come your way. Investing in knowledge allows you to be more confident in the decisions that you make.

Pamela Chiesi - Running Gear That All Novices Should Invest In

When she is not busy with her work as the GCI Financial, LLC’s Chief Administrative Officer, Pamela Chiesi likes to maintain her physical fitness levels by running. The sport can provide a wide range of benefits in terms of cardiovascular conditioning and long-term health, but it is important that you are prepared for the challenges that it presents before you start. One of the areas where novices struggle is picking up the right gear for their runs, so make sure that you have all of the below.

Good Shoes

Above all else, a good pair of running shoes is going to prove essential. If you buy cheap, it is likely that you are going to end up with a pair that is unable to stand up to the rigors of repeated running, plus you will also experience discomfort that can curtail your efforts. Do your research and consider your shoes to be an investment into your future health.

A Water Bottle

Staying hydrated when running is essential, so it is a good idea to pick up a sturdy water bottle that you can take with you. While this is not quite as important for shorter runs, assuming that you have hydrated yourself beforehand, runs that exceed five miles will take a toll on your body, as you will lose moisture due to perspiration.

A Smartphone

Pamela Chiesi notes that modern technology has proven very useful for runners. There are plenty of apps available for download to smartphones that can provide more details on the distances you cover, your speed and overviews of your progress.

Pamela Chiesi - Ways To Think Like A  Chef

Pamela Chiesi has a passion for cooking that can be traced back to her paternal grandfather, who was a French chef who studied under Escoffier in Switzerland. There are few things that she enjoys more than creating wonderful meals to share with her family, but she understands that many people struggle when they first start their kitchen adventures. The following are all ways that you can get into the right mindset for your culinary exploits.

Learn The Basics
Before you can start creating complex dishes that meld different flavors and techniques, it is important that you learn the basics. This is often best achieved by purchasing simple recipe books that will allow you to learn more about how various ingredients go together. As your confidence grows, you will feel more comfortable in experimenting when cooking.

Use Fresh Ingredients
The quality of your cooking is related to a number of factors outside of your own skills as a chef. The freshness of your ingredients will play a large part in how well various flavors are released in your dishes, so it is a good idea to get into the habit of buying fresh. Explore the local market and buy ingredients based on what you want to cook on that day, rather than a few days in the future.

Have Fun
Pamela Chiesi cooks because she has a tremendous amount of fun doing it. This is crucial for people who want to develop their skills, as it provides them with the motivation to keep plugging away, even when things go awry.

Pamela Chiesi — The Challenges Facing Pharmaceutical Innovation

Having worked in the biopharmaceutical and digital healthcare sectors for more than fifteen years of her career, Pamela Chiesi recognizes that there are many challenges that the field must face in order to continue providing innovative products that are beneficial to patients. In recent years, the following challenges have needed to be overcome in order for new products to get released.

Lack of Start-up Funding

Venture capital funding has lowered in recent years, particularly for the first phase of the clinical process. This is because many investors prefer to wait until phase two of the process before committing themselves to the product’s development. Unfortunately, this means that less funding is being pumped into the early stages of product development, often because of the risk involved in investing in a product that may take as many as fifteen years to complete development.

Increased Regulation

Regulation from the Food & Drug Administration is a good thing for the industry in several ways, but many within the field feel as though the onus is currently on caution. This leaves little room for true innovation, as pharmaceutical companies are less willing to try new things for fear of falling foul of current regulations.

Potential Liability

Pamela Chiesi notes that all biopharmaceutical and biotech companies should be liable for the research and development of their products, but there is a pervading sense that the consulting field is becoming fearful of exposing itself to litigation in all areas, from clinical trials through to marketing activities.

Pamela Chiesi - The Benefits of Running

There are several health benefits involved in running. Pamela Chiesi is a regular runner and an active adult. She is also a successful professional in the financial and biopharmaceutical industries. She enjoys staying fit and she works hard to keep herself strong and healthy. She is a hardworking and dedicated professional who enjoys staying active while having fun. There are several reasons for you to start running today.

Running is excellent cardiovascular exercise. This form of exercise can build and maintain heart health and lung health. Cardio exercise can help prevent future heart disease. As your run, your muscles begin to work harder and demand more oxygen. Your blood begins to flow faster, and your heart pumps harder. The heart is a muscle and needs to exercise regularly like any other muscles.

Running is a great way to maintain your weight. Cardiovascular exercise requires a large amount of energy. Your body can convert fat into energy. The more you run, the more fat your body burns. Running multiple times a week can help you lose weight and maintain your weight.

When you run, you use your core muscles as well as the muscles in your legs. Running is a great way to build your major muscle groups and develop strength. Running multiple times a week can help improve your overall health and strength. Pamela Chiesi is a business woman who has experience in finance and biopharmaceuticals. She is also the mother of two and an active woman who enjoys maintaining her fitness levels. 

Pamela Chiesi - Three Facts About Biopharmaceutical Pricing

The biopharmaceutical industry involves research and development, the medical community, and patients. Pamela Chiesi worked as a commercialization strategist for several years. She has experience with analyzing the biopharmaceutical market and helping to determine the pricing of biopharmaceutical products. She worked with information from the medical community including physicians, patients, and third party payers such as insurance companies.

Pricing in the biopharmaceutical and pharmaceutical industries takes several aspects into consideration. An important step in pricing biopharmaceutical products is analyzing the market need for the products. The demand for the product can determine what the price should be. Biopharmaceutical pricing also involves production costs. Pricing specialist analyze how much it costs to produce the products and compare that price to the demand.

Biopharmaceutical pricing also works with health care providers and insurance companies to determine how much a third party payer will cover. The goal of the biopharmaceutical company is to make the product accessible to the medical community while also covering production costs and making a profit. Profitability is necessary in this industry. Biopharmaceutical companies use their revenue to fund research products and to create more treatments, therapies, and medicines.

The biopharmaceutical industry is complex and requires several steps. There are many professionals who work in this field in order to create biomedicines and to make the available to the medical community. Pamela Chiesi a dedicated and hardworking professional in the biopharmaceutical industry. She has fifteen years of experience and she worked hard to develop her knowledge of various treatments, therapies, and biosimilars.

Pamela Chiesi - What is Digital Health?

Pamela Chiesi is an experienced and knowledgeable professional in the biopharmaceutical and financial industries. She began her career in the biopharmaceutical industry in 1994. She spent years developing her experience and in 2000 she began working with Scient Corporation. She worked with e-business and digital health. An important new factor in the health care industry is digital health. This relatively new field can impact physicians as well as patients.  
Technology is a major part of everyday life. Computers, tablets, and smartphones are a common sight. The health care industry is also adopting technology. Digital health is helping people maintain healthier lifestyles and access better health care. Digital health refers to a broad range of products and technology.

One type of digital health care involves wearable technology. Patients can wear technological devices that monitor their physical activity and their heart rate. These devices can help people track their physical health and, in some cases, adopt a healthier lifestyle.

Apps are another type of digital health. Apps such as MyFitnessPal can help individuals lose weight by tracking their calorie intake and their physical activity. There are many apps that track lifestyles and health. As technology improves, digital health increases. There are many startups in this industry and digital health can have a major impact on lifestyle as well as chronic illness. There are many uses for digital health in the health care industry. Pamela Chiesi worked with digital health while she was a managing director with Scient Corporation. She is an experienced and knowledgeable professional in the biopharmaceutical industry.

Source:
http://www.forbes.com/sites/robertglatter/2014/11/20/wearable-technology-and-digital-healthcare-strategies-should-shift-focus-to-chronic-medical-illness/#4d7e881629a7
http://www.theverge.com/2014/7/22/5923849/how-apple-and-google-plan-to-reinvent-healthcare  

Pamela Chiesi - How to Become a  Biopharma Professional

The biopharmaceutical, or biopharma, industry is a major part of the health care field. Pamela Chiesi worked in this industry for fifteen years. In 1994, she accepted a position with Towers Perrin Strategy Consulting. She worked with the company until 2000. She developed new methodologies for assessing patient price sensitivities compared to tiered copays. She built a successful career and was considered one of the most successful lead originators. It takes a lot of hard work and dedication to become a successful professional in the biopharma industry.
 
A great tip for becoming a professional in this field is to choose a specialty. This industry has several facets and can offer a multitude of career opportunities. Some people choose to go into research and development, while others choose to go into marketing. The first step to becoming a biopharmaceutical professional is to choose which facet you wish to work in.
 
A second tip for becoming a successful biopharma professional is to network in your field. Professional connections can be very helpful for future career advancement. It is important to attend professional conferences and to build a large professional network.
 
A third tip for developing a career in this field is to keep current on new research. Biopharmaceutical companies are regularly conducting research. If you want to build a successful career in this industry, you will need to continually read new studies and keep up on new research. Pamela Chiesi is a successful professional who worked hard to build a strong career in this industry. She is experienced as well as knowledgeable.